Agency Forms Undergoing Paperwork Reduction Act Review, 52434-52436 [2016-18710]

Download as PDF 52434 Federal Register / Vol. 81, No. 152 / Monday, August 8, 2016 / Notices writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than September 2, 2016. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Equity Bancshares, Inc., Wichita, Kansas, to acquire 100 percent of the voting shares of Community First Bancshares, Inc., and thereby indirectly acquire control of Community First Bank, both of Harrison, Arkansas. B. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. United Community Bancorp, Inc., Chatham, Illinois; for prior approval to acquire Illini Corporation, Springfield, Illinois and thereby indirectly acquire Illini Bank, Springfield, Illinois and Farmers State Bank of Camp Point, Camp Point, Illinois. Board of Governors of the Federal Reserve System, August 2, 2016. Michele T. Fennell, Assistant Secretary of the Board. [FR Doc. 2016–18691 Filed 8–5–16; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Proposed Project Centers for Disease Control and Prevention [30Day–16–0666] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in mstockstill on DSK3G9T082PROD with NOTICES accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Written comments and/or suggestions regarding the items contained in this notice should be directed to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. National Healthcare Safety Network (NHSN) (OMB No. 0920–0666, Exp. 12/ 31/2018)—Revision—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The National Healthcare Safety Network (NHSN) is a system designed to accumulate, exchange, and integrate relevant information and resources among private and public stakeholders to support local and national efforts to protect patients and promote healthcare safety. Specifically, the data is used to determine the magnitude of various healthcare-associated adverse events and trends in the rates of these events among patients and healthcare workers with similar risks. The data will be used to detect changes in the epidemiology of adverse events resulting from new and current medical therapies and changing risks. The NHSN currently consists of five components: Patient Safety, Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility (LTCF), and Dialysis. The Outpatient Procedure Component is on track to be released in NHSN in 2017/2018. The development of this component has been previously delayed to obtain additional user feedback and support from outside partners. Changes were made to six facility surveys and two new facility surveys were added. Based on user feedback and internal reviews of the annual facility surveys it was determined that questions and response options be amended, removed, or added to fit the evolving uses of the annual facility surveys. The surveys are being increasingly used to help intelligently interpret the other data elements reported into NHSN. Currently the surveys are used to appropriately risk adjust the numerator and denominator data entered into NHSN while also guiding decisions on future division priorities for prevention. Further, three new forms were added to expand NHSN surveillance to pediatric ventilator-associated events, adult sepsis, and custom HAI event surveillance. An additional 14 forms were added to the Hemovigilance Component to streamline data collection/entry for adverse reaction events. Additionally, minor revisions have been made to 22 forms within the package to clarify and/or update surveillance definitions. The previously approved NHSN package included 52 individual collection forms; the current revision request adds nineteen forms and removes one form for a total of 70 forms. The reporting burden will increase by 489,174 hours, for a total of 5,110,716 hours. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... 57.100 NHSN Registration Form ................... 57.101 Facility Contact Information ............... VerDate Sep<11>2014 22:23 Aug 05, 2016 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\08AUN1.SGM 2,000 2,000 08AUN1 Number of responses per respondent 1 1 Avg. burden per response (in hrs.) 5/60 10/60 52435 Federal Register / Vol. 81, No. 152 / Monday, August 8, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents Form name Registered Nurse (Infection Preventionist) ..... 57.103 Patient Safety Component—Annual Hospital Survey. 57.105 Group Contact Information ................ 57.106 Patient Safety Monthly Reporting Plan. 57.108 Primary Bloodstream Infection (BSI) 57.111 Pneumonia (PNEU) ........................... 57.112 Ventilator-Associated Event ............... 57.113 Pediatric Ventilator-Associated Event (PedVAE). 57.114 Urinary Tract Infection (UTI) .............. 57.115 Custom Event .................................... 57.116 Denominators for Neonatal Intensive Care Unit (NICU). 57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC). 57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA). 57.120 Surgical Site Infection (SSI) ............... 57.121 Denominator for Procedure ............... 57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables. 57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy Data Electronic Upload Specification Tables. 57.125 Central Line Insertion Practices Adherence Monitoring. 57.126 MDRO or CDI Infection Form ............ 57.127 MDRO and CDI Prevention Process and Outcome Measures Monthly Monitoring. 57.128 Laboratory-identified MDRO or CDI Event. 57.129 Adult Sepsis ....................................... 57.137 Long-Term Care Facility Component—Annual Facility Survey. 57.138 Laboratory-identified MDRO or CDI Event for LTCF. 57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF. 57.140 Urinary Tract Infection (UTI) for LTCF 57.141 Monthly Reporting Plan for LTCF ...... 57.142 Denominators for LTCF Locations ..... 57.143 Prevention Process Measures Monthly Monitoring for LTCF. 57.150 LTAC Annual Survey ......................... 57.151 Rehab Annual Survey ........................ 57.200 Healthcare Personnel Safety Component Annual Facility Survey. 57.203 Healthcare Personnel Safety Monthly Reporting Plan. 57.204 Healthcare Worker Demographic Data. 57.205 Exposure to Blood/Body Fluids ......... 57.206 Healthcare Worker Prophylaxis/Treatment. 57.207 Follow-Up Laboratory Testing ............ 57.210 Healthcare Worker Prophylaxis/Treatment—Influenza. 57.300 Hemovigilance Module Annual Survey. 57.301 Hemovigilance Module Monthly Reporting Plan. 57.303 Hemovigilance Module Monthly Reporting Denominators. 57.305 Hemovigilance Incident ...................... 57.306 Hemovigilance Module Annual Survey—Non-acute care facility. Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Registered Registered Registered Nurse Nurse Nurse Nurse (Infection (Infection (Infection (Infection Preventionist) Preventionist) Preventionist) Preventionist) ..... ..... ..... ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Registered Nurse (Infection Preventionist) ..... Staff RN .......................................................... Laboratory Technician .................................... Pharmacist ...................................................... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Registered Registered Registered Registered Nurse Nurse Nurse Nurse (Infection (Infection (Infection (Infection Preventionist) Preventionist) Preventionist) Preventionist) ..... ..... ..... ..... Registered Nurse (Infection Preventionist) ..... Registered Nurse (Infection Preventionist) ..... Occupational Health RN/Specialist ................. Occupational Health RN/Specialist ................. Occupational Health RN/Specialist ................. Occupational Health RN/Specialist ................. Occupational Health RN/Specialist ................. mstockstill on DSK3G9T082PROD with NOTICES Laboratory Technician .................................... Occupational Health RN/Specialist ................. Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... VerDate Sep<11>2014 22:23 Aug 05, 2016 Jkt 238001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Number of responses per respondent Avg. burden per response (in hrs.) 5,000 1 55/60 1,000 6,000 1 12 5/60 15/60 6,000 6,000 6,000 2,000 44 72 144 120 30/60 30/60 25/60 25/60 6,000 2,000 6,000 40 91 9 20/60 35/60 3 6,000 9 5 6,000 60 5 6,000 6,000 6,000 36 540 12 35/60 10/60 5/60 6,000 12 5/60 1,000 100 25/60 6,000 6,000 72 24 30/60 15/60 6,000 240 20/60 50 350 250 1 25/60 1.08 350 12 15/60 350 12 10/60 350 350 350 300 14 12 12 12 30/60 5/60 3.35 5/60 400 1,000 50 1 1 1 55/60 55/60 8 17,000 1 5/60 50 200 20/60 50 50 50 30 1 15/60 50 50 50 50 15/60 10/60 500 1 2 500 12 1/60 500 12 1.17 500 200 10 1 10/60 35/60 E:\FR\FM\08AUN1.SGM 08AUN1 52436 Federal Register / Vol. 81, No. 152 / Monday, August 8, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondents Form name Medical/Clinical Laboratory Technologist ....... 57.307 Hemovigilance Adverse Reaction— Acute Hemolytic Transfusion Reaction. 57.308 Hemovigilance Adverse Reaction— Allergic Transfusion Reaction. 57.309 Hemovigilance Adverse Reaction— Delayed Hemolytic Transfusion Reaction. 57.310 Hemovigilance Adverse Reaction— Delayed Serologic Transfusion Reaction. 57.311 Hemovigilance Adverse Reaction— Febrile Non-hemolytic Transfusion Reaction. 57.312 Hemovigilance Adverse Reaction— Hypotensive Transfusion Reaction. 57.313 Hemovigilance Adverse Reaction— Infection. 57.314 Hemovigilance Adverse Reaction— Post Transfusion Purpura. 57.315 Hemovigilance Adverse Reaction— Transfusion Associated Dyspnea. 57.316 Hemovigilance Adverse Reaction— Transfusion Associated Graft vs. Host Disease. 57.317 Hemovigilance Adverse Reaction— Transfusion Related Acute Lung Injury. 57.318 Hemovigilance Adverse Reaction— Transfusion Associated Circulatory Overload. 57.319 Hemovigilance Adverse Reaction— Unknown Transfusion Reaction. 57.320 Hemovigilance Adverse Reaction— Other Transfusion Reaction. 57.400 Patient Safety Component—Annual Facility Survey for Ambulatory Surgery Center (ASC). 57.401 Outpatient Procedure Component— Monthly Reporting Plan. 57.402 Outpatient Procedure Component Event. 57.403 Outpatient Procedure Component— Monthly Denominators and Summary. 57.500 Outpatient Dialysis Center Practices Survey. 57.501 Dialysis Monthly Reporting Plan ........ 57.502 Dialysis Event .................................... 57.503 Denominator for Outpatient Dialysis .. 57.504 Prevention Process Measures Monthly Monitoring for Dialysis. 57.505 Dialysis Patient Influenza Vaccination 57.506 Dialysis Patient Influenza Vaccination Denominator. 57.507 Home Dialysis Center Practices Survey. Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Medical/Clinical Laboratory Technologist ....... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Registered Nurse (Infection Preventionist) ..... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... Staff RN .......................................................... mstockstill on DSK3G9T082PROD with NOTICES Jeffrey M. Zirger, Health Scientist, Acting Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–18710 Filed 8–5–16; 8:45 am] [30Day–16–0010] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request VerDate Sep<11>2014 22:23 Aug 05, 2016 Jkt 238001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Number of responses per respondent Avg. burden per response (in hrs.) 500 4 25/60 500 4 25/60 500 1 25/60 500 2 25/60 500 4 25/60 500 1 25/60 500 1 25/60 500 1 25/60 500 1 25/60 500 1 25/60 500 1 25/60 500 2 25/60 500 1 25/60 500 1 25/60 5,000 1 5/60 5,000 12 15/60 5,000 25 40/60 5,000 12 40/60 6,500 1 2.0 6,500 6,500 6,500 1,500 12 60 12 12 5/60 25/60 10/60 1.25 325 325 75 5 10/60 10/60 600 1 25/60 to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the E:\FR\FM\08AUN1.SGM 08AUN1

Agencies

[Federal Register Volume 81, Number 152 (Monday, August 8, 2016)]
[Notices]
[Pages 52434-52436]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18710]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-0666]

Agency Forms Undergoing Paperwork Reduction Act Review

The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.

Proposed Project

National Healthcare Safety Network (NHSN) (OMB No. 0920-0666, Exp.
12/31/2018)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).

Background and Brief Description

The National Healthcare Safety Network (NHSN) is a system designed
to accumulate, exchange, and integrate relevant information and
resources among private and public stakeholders to support local and
national efforts to protect patients and promote healthcare safety.
Specifically, the data is used to determine the magnitude of various
healthcare-associated adverse events and trends in the rates of these
events among patients and healthcare workers with similar risks. The
data will be used to detect changes in the epidemiology of adverse
events resulting from new and current medical therapies and changing
risks. The NHSN currently consists of five components: Patient Safety,
Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility
(LTCF), and Dialysis. The Outpatient Procedure Component is on track to
be released in NHSN in 2017/2018. The development of this component has
been previously delayed to obtain additional user feedback and support
from outside partners.
Changes were made to six facility surveys and two new facility
surveys were added. Based on user feedback and internal reviews of the
annual facility surveys it was determined that questions and response
options be amended, removed, or added to fit the evolving uses of the
annual facility surveys. The surveys are being increasingly used to
help intelligently interpret the other data elements reported into
NHSN. Currently the surveys are used to appropriately risk adjust the
numerator and denominator data entered into NHSN while also guiding
decisions on future division priorities for prevention.
Further, three new forms were added to expand NHSN surveillance to
pediatric ventilator-associated events, adult sepsis, and custom HAI
event surveillance. An additional 14 forms were added to the
Hemovigilance Component to streamline data collection/entry for adverse
reaction events.
Additionally, minor revisions have been made to 22 forms within the
package to clarify and/or update surveillance definitions. The
previously approved NHSN package included 52 individual collection
forms; the current revision request adds nineteen forms and removes one
form for a total of 70 forms. The reporting burden will increase by
489,174 hours, for a total of 5,110,716 hours.

Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
Registered Nurse (Infection 57.100 NHSN Registration 2,000 1 5/60
Preventionist). Form.
Registered Nurse (Infection 57.101 Facility Contact 2,000 1 10/60
Preventionist). Information.

[[Page 52435]]

Registered Nurse (Infection 57.103 Patient Safety 5,000 1 55/60
Preventionist). Component--Annual Hospital
Survey.
Registered Nurse (Infection 57.105 Group Contact 1,000 1 5/60
Preventionist). Information.
Registered Nurse (Infection 57.106 Patient Safety 6,000 12 15/60
Preventionist). Monthly Reporting Plan.
Registered Nurse (Infection 57.108 Primary Bloodstream 6,000 44 30/60
Preventionist). Infection (BSI).
Registered Nurse (Infection 57.111 Pneumonia (PNEU).... 6,000 72 30/60
Preventionist).
Registered Nurse (Infection 57.112 Ventilator- 6,000 144 25/60
Preventionist). Associated Event.
Registered Nurse (Infection 57.113 Pediatric Ventilator- 2,000 120 25/60
Preventionist). Associated Event (PedVAE).
Registered Nurse (Infection 57.114 Urinary Tract 6,000 40 20/60
Preventionist). Infection (UTI).
Registered Nurse (Infection 57.115 Custom Event........ 2,000 91 35/60
Preventionist).
Staff RN........................... 57.116 Denominators for 6,000 9 3
Neonatal Intensive Care
Unit (NICU).
Staff RN........................... 57.117 Denominators for 6,000 9 5
Specialty Care Area (SCA)/
Oncology (ONC).
Staff RN........................... 57.118 Denominators for 6,000 60 5
Intensive Care Unit (ICU)/
Other locations (not NICU
or SCA).
Registered Nurse (Infection 57.120 Surgical Site 6,000 36 35/60
Preventionist). Infection (SSI).
Staff RN........................... 57.121 Denominator for 6,000 540 10/60
Procedure.
Laboratory Technician.............. 57.123 Antimicrobial Use 6,000 12 5/60
and Resistance (AUR)--
Microbiology Data
Electronic Upload
Specification Tables.
Pharmacist......................... 57.124 Antimicrobial Use 6,000 12 5/60
and Resistance (AUR)--
Pharmacy Data Electronic
Upload Specification
Tables.
Registered Nurse (Infection 57.125 Central Line 1,000 100 25/60
Preventionist). Insertion Practices
Adherence Monitoring.
Registered Nurse (Infection 57.126 MDRO or CDI 6,000 72 30/60
Preventionist). Infection Form.
Registered Nurse (Infection 57.127 MDRO and CDI 6,000 24 15/60
Preventionist). Prevention Process and
Outcome Measures Monthly
Monitoring.
Registered Nurse (Infection 57.128 Laboratory- 6,000 240 20/60
Preventionist). identified MDRO or CDI
Event.
Registered Nurse (Infection 57.129 Adult Sepsis........ 50 250 25/60
Preventionist).
Registered Nurse (Infection 57.137 Long-Term Care 350 1 1.08
Preventionist). Facility Component--Annual
Facility Survey.
Registered Nurse (Infection 57.138 Laboratory- 350 12 15/60
Preventionist). identified MDRO or CDI
Event for LTCF.
Registered Nurse (Infection 57.139 MDRO and CDI 350 12 10/60
Preventionist). Prevention Process
Measures Monthly
Monitoring for LTCF.
Registered Nurse (Infection 57.140 Urinary Tract 350 14 30/60
Preventionist). Infection (UTI) for LTCF.
Registered Nurse (Infection 57.141 Monthly Reporting 350 12 5/60
Preventionist). Plan for LTCF.
Registered Nurse (Infection 57.142 Denominators for 350 12 3.35
Preventionist). LTCF Locations.
Registered Nurse (Infection 57.143 Prevention Process 300 12 5/60
Preventionist). Measures Monthly
Monitoring for LTCF.
Registered Nurse (Infection 57.150 LTAC Annual Survey.. 400 1 55/60
Preventionist).
Registered Nurse (Infection 57.151 Rehab Annual Survey. 1,000 1 55/60
Preventionist).
Occupational Health RN/Specialist.. 57.200 Healthcare Personnel 50 1 8
Safety Component Annual
Facility Survey.
Occupational Health RN/Specialist.. 57.203 Healthcare Personnel 17,000 1 5/60
Safety Monthly Reporting
Plan.
Occupational Health RN/Specialist.. 57.204 Healthcare Worker 50 200 20/60
Demographic Data.
Occupational Health RN/Specialist.. 57.205 Exposure to Blood/ 50 50 1
Body Fluids.
Occupational Health RN/Specialist.. 57.206 Healthcare Worker 50 30 15/60
Prophylaxis/Treatment.
Laboratory Technician.............. 57.207 Follow-Up Laboratory 50 50 15/60
Testing.
Occupational Health RN/Specialist.. 57.210 Healthcare Worker 50 50 10/60
Prophylaxis/Treatment--
Influenza.
Medical/Clinical Laboratory 57.300 Hemovigilance Module 500 1 2
Technologist. Annual Survey.
Medical/Clinical Laboratory 57.301 Hemovigilance Module 500 12 1/60
Technologist. Monthly Reporting Plan.
Medical/Clinical Laboratory 57.303 Hemovigilance Module 500 12 1.17
Technologist. Monthly Reporting
Denominators.
Medical/Clinical Laboratory 57.305 Hemovigilance 500 10 10/60
Technologist. Incident.
Medical/Clinical Laboratory 57.306 Hemovigilance Module 200 1 35/60
Technologist. Annual Survey--Non-acute
care facility.

[[Page 52436]]

Medical/Clinical Laboratory 57.307 Hemovigilance 500 4 25/60
Technologist. Adverse Reaction--Acute
Hemolytic Transfusion
Reaction.
Medical/Clinical Laboratory 57.308 Hemovigilance 500 4 25/60
Technologist. Adverse Reaction--Allergic
Transfusion Reaction.
Medical/Clinical Laboratory 57.309 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--Delayed
Hemolytic Transfusion
Reaction.
Medical/Clinical Laboratory 57.310 Hemovigilance 500 2 25/60
Technologist. Adverse Reaction--Delayed
Serologic Transfusion
Reaction.
Medical/Clinical Laboratory 57.311 Hemovigilance 500 4 25/60
Technologist. Adverse Reaction--Febrile
Non-hemolytic Transfusion
Reaction.
Medical/Clinical Laboratory 57.312 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--
Hypotensive Transfusion
Reaction.
Medical/Clinical Laboratory 57.313 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--
Infection.
Medical/Clinical Laboratory 57.314 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--Post
Transfusion Purpura.
Medical/Clinical Laboratory 57.315 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--
Transfusion Associated
Dyspnea.
Medical/Clinical Laboratory 57.316 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--
Transfusion Associated
Graft vs. Host Disease.
Medical/Clinical Laboratory 57.317 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--
Transfusion Related Acute
Lung Injury.
Medical/Clinical Laboratory 57.318 Hemovigilance 500 2 25/60
Technologist. Adverse Reaction--
Transfusion Associated
Circulatory Overload.
Medical/Clinical Laboratory 57.319 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--Unknown
Transfusion Reaction.
Medical/Clinical Laboratory 57.320 Hemovigilance 500 1 25/60
Technologist. Adverse Reaction--Other
Transfusion Reaction.
Medical/Clinical Laboratory 57.400 Patient Safety 5,000 1 5/60
Technologist. Component--Annual Facility
Survey for Ambulatory
Surgery Center (ASC).
Staff RN........................... 57.401 Outpatient Procedure 5,000 12 15/60
Component--Monthly
Reporting Plan.
Staff RN........................... 57.402 Outpatient Procedure 5,000 25 40/60
Component Event.
Staff RN........................... 57.403 Outpatient Procedure 5,000 12 40/60
Component--Monthly
Denominators and Summary.
Staff RN........................... 57.500 Outpatient Dialysis 6,500 1 2.0
Center Practices Survey.
Registered Nurse (Infection 57.501 Dialysis Monthly 6,500 12 5/60
Preventionist). Reporting Plan.
Staff RN........................... 57.502 Dialysis Event...... 6,500 60 25/60
Staff RN........................... 57.503 Denominator for 6,500 12 10/60
Outpatient Dialysis.
Staff RN........................... 57.504 Prevention Process 1,500 12 1.25
Measures Monthly
Monitoring for Dialysis.
Staff RN........................... 57.505 Dialysis Patient 325 75 10/60
Influenza Vaccination.
Staff RN........................... 57.506 Dialysis Patient 325 5 10/60
Influenza Vaccination
Denominator.
Staff RN........................... 57.507 Home Dialysis Center 600 1 25/60
Practices Survey.
----------------------------------------------------------------------------------------------------------------

Jeffrey M. Zirger,
Health Scientist, Acting Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the Associate Director for
Science, Office of the Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016-18710 Filed 8-5-16; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.